Transformation of ALK expression and PD-L1 0% to PD-L1 90% only after surgery: the need for rebiopsy in lung cancer patients

Lung cancer is still diagnosed at a late stage although novel diagnostic techniques are in use. However, as pharmacogenomics have evolved novel targeted therapies either with tyrosine kinase inhibitors or immunotherapy can be currently used as daily treatment. We present the case of a woman with ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Kosmidis, Christoforos, Koimtzis, Georgios, Giannakidis, Dimitrios, Tteralli, Nikos, Mantalovas, Stylianos, Tsakalidis, Alexandros, Tsopouridou, Konstantina, Atmatzidis, Stefanos, Liavas, Lazaros, Zarogoulidis, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333155/
https://www.ncbi.nlm.nih.gov/pubmed/30666169
http://dx.doi.org/10.2147/IMCRJ.S191526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333155/
https://www.ncbi.nlm.nih.gov/pubmed/30666169
http://dx.doi.org/10.2147/IMCRJ.S191526

Ejemplares similares